Prolonged hyperlipidemia exposure increases the risk of arterial stiffness in young adults: a cross-sectional study in a cohort of Chinese

Table 3 The effects of hyperlipidemia on arterial stiffness without recommended for statin therapy at baseline^a

Group		Model 1 OR (95% CI)	P	P trend	Model 2 OR (95% CI)	P	P trend
Age (year)	variable	Model 1 OR (95% CI)	P	P trend	Model 2 OR (95% CI)	P	P trend
[35–55]	0	1(Ref)			1(Ref)
	[1–5)	1.42 (1.30–1.56)	< 0.01		1.16 (1.03–1.30)	< 0.01
	[5–10]	2.03 (1.84–2.25)	< 0.01	< 0.01	1.38 (1.20–1.59)	< 0.01	< 0.01
[35–40)	0	1(Ref)			1(Ref)
	[1–5)	1.63 (1.32–2.00)	< 0.01		1.18 (0.91–1.54)	0.23
	[5–10]	1.90 (1.48–2.44)	< 0.01	< 0.01	1.18 (0.84–1.65)	0.36	0.30
[40–45)	0	1(Ref)			1(Ref)
	[1–5)	1.51 (1.24–1.84)	< 0.01		1.25 (0.99–1.65)	0.05
	[5–10]	2.23 (1.79–2.78)	< 0.01	< 0.01	1.52 (1.13–2.06)	< 0.01	< 0.01
[45–50)	0	1(Ref)			1(Ref)
	[1–5)	1.26 (1.07–1.50)	0.01		1.14 (0.93–1.41)	0.26
	[5–10]	1.72 (1.43–2.07)	< 0.01	< 0.01	1.37 (1.07–1.76)	0.02	0.02
[50–55]	0	1(Ref)			1(Ref)
	[1–5)	1.07 (0.85–1.22)	0.86		1.07 (0.84–1.34)	0.66
	[5–10]	1.38 (1.34–1.68)	< 0.01	< 0.01	1.38 (1.05–1.81)	0.03	0.02

Model 1 unadjust;
Model 2 adjust age, gender, systolic blood pressure, high-density lipoprotein cholesterol, waist circumference, physical exercise, anti-hypertensive treatment, smoking, alcohol consumption, diabetes, baseline low-density lipoprotein cholesterol;
^alow-density lipoprotein cholesterol ≥4.9 or total cholesterol ≥7.2; diabetes and 1.8 ≤ low-density lipoprotein cholesterol < 4.9 or 3.1 ≤ total cholesterol< 7.2 and age ≥ 40

ISSN: 1471-2458